The OMERACT glossary is a list of terms used in OMERACT along with their abbreviations and definitions
We created this glossary to facilitate learning about OMERACT by keeping terminology variations and acronyms defined. We hope the glossary is used to ensure that all stakeholders understand what is meant by the terminology, acronyms, and phrases used inside OMERACT & our working groups.
While creating the glossary has evolved over the years and taken a vast amount of time there are many benefits, such as:
- Providing clear definitions of important OMERACT terms
- Encouraging more effective communication among stakeholders, by resolving terminology disagreements.
- A PRIORI
- ABSENTEEISM
- ABSTRACT
- ACR 20 RESPONSE
- ACR 50 RESPONSE
- ACR 70 RESPONSE
- ACR CORE SET
- ACTIVE COMPARISON ARM
- ADHERENCE
- Medication Adherence
- ADVERSE EVENTS
- AMERICAN COLLEGE OF RHEUMATOLOGY
- ANCA-ASSOCIATED VASCULITIS
- ANCA-ASSOCIATED VASCULITIS
- ANCA-ASSOCIATED VASCULITIS
- ANKYLOSING SPONDYLITIS
- ANTI-TUMOUR NECROSIS FACTOR
- AREA UNDER THE CURVE (AUC)
- ARTHROPLASTY
- ARTHROSCOPY
- ATTRIBUTE
- BASELINE
- BASELINE DISTRIBUTION
- BASIC SCIENTIFIC RESEARCH
- BENEFITS
- BIAS
- BIOLOGICAL MARKER
- Biomarker
- BIOLOGICAL MARKER
- Biomarker
- BIOLOGICAL RESPONSE MODIFIER
- BIOLOGICS
- BIOMARKER
- BIOMARKERS AS PREDICTORS OF STRUCTURAL DAMAGE IN RHEUMATOID ARTHRITIS
- BIOMARKERS AS PREDICTORS OF STRUCTURAL DAMAGE IN RHEUMATOID ARTHRITIS
- BIOMARKERS AS PREDICTORS OF STRUCTURAL DAMAGE IN RHEUMATOID ARTHRITIS
- BIOMEDICAL RESEARCH
- BLINDED TRIAL
- BONE AND JOINT DECADE
- BOOLEAN
- BRISTOL RHEUMATOID ARTHRITIS FATIGUE SCALES
- BRISTOL RHEUMATOID FATIGUE MULTI-DIMENSIONAL QUESTIONNAIRE (BRAF MDQ)
- CALCIUM PYROPHOSPHATE CRYSTALS
- CAREGIVER
- CASE STUDY
- CHRONIC
- CHRONIC NONBAACTERIAL OSTEOMYELITIS
- CLASSIFICATION AND DIAGNOSTIC CRITERIA
- CLINEMETRIC
- CLINICAL MEANINGFULNESS
- CLINICAL OUTCOME ASSESSMENT
- CLINICAL OUTCOME ASSESSMENT
- CLINICAL TRIAL
- CLINICAL TRIAL PROTOCOL DEVELOPMENT
- CLINICALLY RELEVANT
- CLINICIAN-REPORTED OUTCOME (CLINRO)
- CLINIMETRY
- COCHRANE
- COCHRANE REVIEW
- COCHRANE SUMMARY OF FINDINGS TABLE
- COGNITIVE BEHAVIOURAL THERAPY
- COHORT STUDY
- COMORBIDITY
- COMPARATIVE EFFECTIVENESS RESEARCH
- COMPOSITE MEASURE
- COMPOSITE OUTCOME MEASURE
- Composite
- CONCEPT ELICITATION
- CONCEPT OF INTEREST
- CONCEPTUAL FRAMEWORK
- CONCOMITANT
- CONSENSUS
- COnsensus-based Standards for the selection of health Measurement Instruments
- CONSENSUS MEETING
- CONSENSUS THRESHOLD
- CONSOLIDATED STANDARDS OF REPORTING TRIALS
- CONSORT-SURROGATE
- CONSTRUCT VALIDITY
- CONTENT VALIDITY
- CONTEXTUAL FACTORS
- CONTROL GROUP/ CONTROLLED STUDY
- CORE AREA
- CORE DOMAIN
- Core Outcome Domain
- CORE DOMAIN SET
- Core Outcome Domain Set
- CORE OUTCOME MEASUREMENT SELECTION
- CORE OUTCOME MEASUREMENT SET
- CORE OUTCOME MEASURES
- outcome measurement instrument
- instrument
- measurement instrument
- CORE OUTCOME MEASURES IN EFFECTIVENESS TRIALS
- CORE OUTCOME REGISTRY
- CORE OUTCOME SET
- Core Set
- COS
- Core Outcome Measurement Set
- CORE OUTCOME SET-STANDARDISED PROTOCOL
- CORE OUTCOME SET-STANDARDISED PROTOCOL
- CORE OUTCOME SET - STANDARDISED PROTOCOL ITEMS
- CORE OUTCOME SET-STANDARDS FOR REPORTING
- CORE OUTCOME SET UPTAKE
- CORE OUTCOME TAXONOMY
- CORTICOSTEROID
- COSMIN
- COVIDENCE
- CRITERION VALIDITY
- CRITICAL APPRAISAL
- CRITICAL STAKEHOLDERS
- CROSS-SECTIONAL
- CUMULATIVE DISTRIBUTION FUNCTION
- DATA EXTRACTION
- DATA MINING
- DECISION SUPPORT
- DELPHI MANAGER
- DELPHI METHOD
- DISCRIMINATION
- DISEASE ACTIVITY
- DISEASE ACTIVITY SCORE
- DISEASE BURDEN
- DISEASE MODIFYING ANTI-RHEUMATIC DRUG
- DISSEMINATION
- DISSENSUS
- DISTILLER SR
- DOMAIN
- Outcome Domain
- concept
- item
- DOMAIN DEFINITION REPORT
- DOMAIN DEFINITION TRACKING SHEET
- DOMAIN WORKBOOK
- DUAL USE COS
- EFFECT SIZE /(STANDARDIZED EFFECT SIZE)
- EFFECTIVENESS
- EFFECTIVENESS TRIALS
- EFFICACY
- EFFICIENCY
- EMPIRICAL
- EMPOWERMENT
- ENDPOINTS
- ENTHESITIS – ALSO CALLED ENTHESOPATHY
- ENTHESITIS/ENTHESOPATHY
- EPIDEMIOLOGICAL
- EROSIONS
- EULAR CRITERIA – EULAR RESPONSE CRITERIA
- EUROPEAN LEAGUE AGAINST RHEUMATISM (EULAR)
- EVIDENCE
- EVIDENCE BASED MEDICINE
- EXCLUSION CRITERIA
- FACE VALIDITY
- FEASIBILITY
- FELLOW
- FIT-FOR-PURPOSE
- FLARES
- FOCUS GROUP
- GLOBAL CRE OUTCOME SET
- GOLD STANDARD
- GRADE
- Grading of Recommendations Assessment, Development and Evaluation
- Grading of Recommendations Assessment, Development and Evaluation
- GROUP FOR RESEARCH AND ASSESSMENT OF PSORIASIS AND PSORIATIC ARTHRITIS
- GROUP FOR RESEARCH AND ASSESSMENT OF PSORIASIS AND PSORIATIC ARTHRITIS (GRAPPA)
- HARMS AND SIDE EFFECTS
- HEALTH ASSESSMENT QUESTIONNAIRE
- HEALTH INEQUALITY
- HEALTH INTERVENTION
- HEALTH LITERACY
- HEALTH RELATED QUALITY OF LIFE
- HYPOTHESIS
- IDIOPATHIC
- INCLUSION CRITERIA
- INFLAMMATION
- INFORMED CONSENT
- INSTRUMENT
- outcome measurement instrument
- outcome measure
- INTERMEDIATE OUTCOME
- INTERNATIONAL CLASSIFICATION OF FUNCTIONING
- INTERNATIONAL DERMATOLOGY OUTCOME MEASURES GROUP (IDEOM)
- ITEM RESPONSE THEORY
- ITERATIVE
- KNOWLEDGE TRANSLATION
- LIFE IMPACT
- LIFE IMPACT MEASURES
- LIKERT SCALE
- LITERACY
- LITERATURE REVIEW
- LITERATURE SEARCH
- LOCAL ANESTHETIC/LOCAL ANALGESIA
- LONGITUDINAL OBSERVATIONAL STUDIES
- LONGITUDINAL OBSERVATIONAL STUDIES
- LONGITUDINAL OBSERVATIONAL STUDIES
- MAGNETIC RESONANCE IMAGING
- MANIFESTATIONS/ABNORMALITIES
- ICF body functions and structures
- MEDLINE
- META-ANALYSIS
- METHODOLOGICAL
- METHODOLOGIST
- METHODOLOGY
- MINIMAL CLINICALLY IMPORTANT DIFFERENCE
- MIXED METHODS RESEARCH
- MORTALITY
- MULTI-DISCIPLINARY
- MULTI-STAKEHOLDER APPROACH
- MULTI-STAKEHOLDER ENGAGEMENT
- MULTI-STAKEHOLDER ENGAGEMENT
- MYOSITIS
- NARRATIVE REVIEW
- NOMINAL GROUP TECHNIQUE
- NON-CORE OUTCOMES
- NON-INFERIORITY STUDY
- NON-RANDOMIZED STUDY
- NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
- NSAID
- NUMERIC RATING SCALE
- OBSERVATIONAL INTERVENTIONAL RESEARCH
- OBSERVER-REPORTED OUTCOME
- OMERACT
- OMERACT CORE AREA
- OMERACT CORE DOMAIN SET
- OMERACT CORE OUTCOME MEASUREMENT SET
- OMERACT FILTER
- OMERACT Filter 2.2
- TDF
- Filter
- OMERACT FILTER INSTRUMENT SELECTION ALGORITH
- OMERACT FRAMEWORK
- OMERACT MASTER CHECKLIST FOR DOMAIN SET DEVELOPMENT
- OMERACT MASTER CHECKLIST FOR INSTRUMENT SELECTION
- OMERACT METHODOLOGY
- OMERACT ONION
- onion
- OMERACT WORKING GROUP
- OUTCOME
- OUTCOME DOMAIN COMPONENTS
- OUTCOME TAXONOMY
- PARADIGM
- PATHOPHYSIOLOGY
- PATIENT
- PATIENT CENTERED OUTCOMES
- PATIENT DECISION AID
- PATIENT EXPERIENCE DATA
- PATIENT-FOCUSED
- PATIENT-CENTERED
- PATIENT-FOCUSED
- PATIENT-CENTERED
- PATIENT GLOBAL ASSESSMENT
- PATIENT GLOBAL ASSESSMENT
- PATIENT INPUT
- PATIENT OR PARTICIPANT RELEVANT FINAL OUTCOME
- PATIENT PREFERENCE INFORMATION (PPI)
- PATIENT REPORTED OUTCOME
- PATIENT REPORTED OUTCOME
- PATIENT REPORTED OUTCOME
- PATIENT REPORTED OUTCOME MEASURE
- patient-reported scales
- PATIENT REPORTED OUTCOME MEASURE
- patient-reported scales
- PATIENT REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM (PROMIS®)
- PATIENT-REPORTED SCALES
- PATIENT RESEARCH PARTNER
- PEER REVIEW
- PERFORMANCE OUTCOME
- PHYSICIAN GLOBAL ASSESSMENT
- PHYSICIAN GLOBAL ASSESSMENT
- PICO
- PICOC
- PLACEBO
- POLYMYALGIA
- POLYMYALGIA
- POLYMYALGIA
- POST-HOC ANALYSIS
- post hoc testing
- post hoc comparisons
- PRACTITIONER
- PREFERRED REPORTING ITEMS FOR META-ANALYSIS
- PRESENTEEISM
- PRIMARY OUTCOME
- PROGRESS-PLUS
- PROSPECTIVE STUDY
- PROSPERO
- PROTOCOL
- PSYCHOMETRIC
- PUBMED
- Q-METHODOLOGY STUDY
- QUALITATIVE RESEARCH
- QUALITY APPRAISAL
- QUANTITATIVE RESEARCH
- RANDOMISED CONTROLLED TRIAL
- RANDOMISED CONTROLLED TRIAL (RCTS)
- RASCH ANALYSIS
- REAL-WORLD DATA
- REAL-WORLD DATA
- REAL WORLD EVIDENCE
- REAL WORLD EVIDENCE
- REMISSION
- RESEARCH AGENDA DOMAINS
- RESEARCH PROTOCOL
- RESPONSIVENESS
- RETROSPECTIVE STUDY
- RHEUMATOID ARTHRITIS CORE SET
- RHEUMATOID FACTOR
- RISK OF BIAS
- RISK OF BIAS
- RISK OF BIAS ASSESSMENT
- ROADMAP
- SCOPING REVIEW
- SELF-EFFICACY
- SELF MANAGEMENT
- SENSITIVITY
- SETTING
- scope
- SETTING
- scope
- SHORT-FORM 6-DIMENSION
- SHORT-FORM 12
- SHORT-FORM 36
- SIGNIFICANT
- SMALLEST DETECTABLE DIFFERENCE
- SOCIAL MEDIA
- SOCIAL SUPPORT
- SOCIETAL/RESOURCE USE
- SPECIAL INTEREST GROUP
- SPECIAL INTEREST GROUP
- SPECIAL INTEREST GROUP
- SPECIFITY
- SPIRIT OF OMERACT
- SPIRIT-SURROGATE
- STAKEHOLDER
- STAKEHOLDER
- STANDARD PROTOCOL ITEMS: RECOMMENDATIONS FOR INTERVENTIONAL TRIALS
- STANDARDIZED RESPONSE MEAN (SRM)
- STEROID INJECTIONS
- STRATIFICATION
- SUMMARY OF MEASUREMENT PROPERTIES TABLE
- SURROGATE ENDPOINT
- SURROGATE ENDPOINT
- SURROGATE OUTCOMES
- SURROGATE PRIMARY ENDPOINT
- SURROGATE THRESHOLD EFFECT (STE)
- SYNOVITIS
- SYNOVIUM
- SYSTEMATIC REVIEW
- SYSTEMIC
- T-CELLS
- TARGET POPULATION
- TECHNICAL ADVISORY GROUP (TAG)
- TEST-RETEST RELIABILITY (DISCRIMINATION)
- THE OMERACT WAY
- THRESHOLDS OF MEANING
- TOKENISM
- TRADE-OFF
- TREATMENT BURDEN
- TREATMENT EFFECT:
- TREATMENT EFFECT:
- TREATMENT EFFECT SIZE
- TREATMENT OUTCOME
- TRIAL REGISTRY ENTRY APPROACH
- TRUTH
- TRUTH, DISCRIMINATION AND FEASIBILITY
- ULTRASOUND
- UMBRELLA COS ORGANIZATION
- UVEITIS
- VALIDATION
- VALIDITY – (EXTERNAL)
- VALIDITY– (INTERNAL)
- VALUES
- VALUES CLARIFICATION
- VARIABLE
- VISUAL ANALOGUE SCALE
- WORKSHOP